Versant Venture Capital Vi, L.P. Graphite Bio, Inc. (GRPH) insider trading activity

Versant Venture Capital Vi, L.P. is of Graphite Bio, Inc.. Currently has a direct ownership of 14.7 Million shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on Jun 29, 2021, when has been sold 12,343,727 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.7M

0% 3M change

0% 12M change

Total Value Held $0

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 29 2021	BUY Conversion of derivative security	-	12,343,727 Added 45.63%	14,708,398 Common Stock

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OYST

Oyster Point Pharma, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

TPST

Tempest Therapeutics, Inc. Healthcare

VVC